15-49283602-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_002044.4(GALK2):c.640G>T(p.Asp214Tyr) variant causes a missense change. The variant allele was found at a frequency of 0.00000868 in 1,613,778 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D214N) has been classified as Uncertain significance.
Frequency
Consequence
NM_002044.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GALK2 | NM_002044.4 | c.640G>T | p.Asp214Tyr | missense_variant | 7/10 | ENST00000560031.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GALK2 | ENST00000560031.6 | c.640G>T | p.Asp214Tyr | missense_variant | 7/10 | 1 | NM_002044.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152098Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000876 AC: 22AN: 251212Hom.: 0 AF XY: 0.0000663 AC XY: 9AN XY: 135756
GnomAD4 exome AF: 0.00000684 AC: 10AN: 1461562Hom.: 0 Cov.: 30 AF XY: 0.00000550 AC XY: 4AN XY: 727086
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152216Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74422
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 12, 2024 | The c.640G>T (p.D214Y) alteration is located in exon 7 (coding exon 7) of the GALK2 gene. This alteration results from a G to T substitution at nucleotide position 640, causing the aspartic acid (D) at amino acid position 214 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at